ArticleJournal of general internal medicine2026

Trends in GLP-1 Receptor Agonist and SGLT2-Inhibitor Utilization and Expenditure Between 2017-2023: Demographic, Income, and Insurance Associations.

Molly Jacobs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.